Evidence map›Paper›PMID 35040805›Full record

ArticleCMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne2021

Intracranial hemorrhage after head injury among older patients on anticoagulation seen in the emergency department: a population-based cohort study.

Keerat Grewal, Clare L Atzema, Peter C Austin, Kerstin de Wit, Sunjay Sharma, Nicole Mittmann, Bjug Borgundvaag, Shelley L McLeod

Open access · goldAbstract read
In one paragraph

Article in CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.0field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2021
    Article
  9. Outdated criteria for drug plan reimbursement obstruct evidence-based care.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2021
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Keerat GrewalSchwartz/Reisman Emergency Medicine Institute (Grewal, Borgundvaag, McLeod), Sinai Health; Division of Emergency Medicine (Grewal, Atzema), Department of Medicine, University of Toronto; ICES Central ( Grewal, Atzema, Austin); Department of Emergency Services (Atzema), Sunnybrook Health Sciences Centre, Toronto, Ont.; Department of Emergency Medicine (de Wit), Queen's University, Kingston, Ont.; McMaster University (Sharma), Hamilton, Ont.; Sunnybrook Research Institute (Mittmann), Sunnybrook Health Sciences Centre; Department of Pharmacology and Toxicology, and Institute for Health Policy Management and Evaluation (Mittmann), and Department of Family and Community Medicine (Borgundvaag, McLeod), University of Toronto, Toronto, Ont. Keerat.grewal@sinaihealth.ca.
Clare L AtzemaSchwartz/Reisman Emergency Medicine Institute (Grewal, Borgundvaag, McLeod), Sinai Health; Division of Emergency Medicine (Grewal, Atzema), Department of Medicine, University of Toronto; ICES Central ( Grewal, Atzema, Austin); Department of Emergency Services (Atzema), Sunnybrook Health Sciences Centre, Toronto, Ont.; Department of Emergency Medicine (de Wit), Queen's University, Kingston, Ont.; McMaster University (Sharma), Hamilton, Ont.; Sunnybrook Research Institute (Mittmann), Sunnybrook Health Sciences Centre; Department of Pharmacology and Toxicology, and Institute for Health Policy Management and Evaluation (Mittmann), and Department of Family and Community Medicine (Borgundvaag, McLeod), University of Toronto, Toronto, Ont.
Peter C AustinSchwartz/Reisman Emergency Medicine Institute (Grewal, Borgundvaag, McLeod), Sinai Health; Division of Emergency Medicine (Grewal, Atzema), Department of Medicine, University of Toronto; ICES Central ( Grewal, Atzema, Austin); Department of Emergency Services (Atzema), Sunnybrook Health Sciences Centre, Toronto, Ont.; Department of Emergency Medicine (de Wit), Queen's University, Kingston, Ont.; McMaster University (Sharma), Hamilton, Ont.; Sunnybrook Research Institute (Mittmann), Sunnybrook Health Sciences Centre; Department of Pharmacology and Toxicology, and Institute for Health Policy Management and Evaluation (Mittmann), and Department of Family and Community Medicine (Borgundvaag, McLeod), University of Toronto, Toronto, Ont.
Kerstin de WitSchwartz/Reisman Emergency Medicine Institute (Grewal, Borgundvaag, McLeod), Sinai Health; Division of Emergency Medicine (Grewal, Atzema), Department of Medicine, University of Toronto; ICES Central ( Grewal, Atzema, Austin); Department of Emergency Services (Atzema), Sunnybrook Health Sciences Centre, Toronto, Ont.; Department of Emergency Medicine (de Wit), Queen's University, Kingston, Ont.; McMaster University (Sharma), Hamilton, Ont.; Sunnybrook Research Institute (Mittmann), Sunnybrook Health Sciences Centre; Department of Pharmacology and Toxicology, and Institute for Health Policy Management and Evaluation (Mittmann), and Department of Family and Community Medicine (Borgundvaag, McLeod), University of Toronto, Toronto, Ont.
Sunjay SharmaSchwartz/Reisman Emergency Medicine Institute (Grewal, Borgundvaag, McLeod), Sinai Health; Division of Emergency Medicine (Grewal, Atzema), Department of Medicine, University of Toronto; ICES Central ( Grewal, Atzema, Austin); Department of Emergency Services (Atzema), Sunnybrook Health Sciences Centre, Toronto, Ont.; Department of Emergency Medicine (de Wit), Queen's University, Kingston, Ont.; McMaster University (Sharma), Hamilton, Ont.; Sunnybrook Research Institute (Mittmann), Sunnybrook Health Sciences Centre; Department of Pharmacology and Toxicology, and Institute for Health Policy Management and Evaluation (Mittmann), and Department of Family and Community Medicine (Borgundvaag, McLeod), University of Toronto, Toronto, Ont.
Nicole MittmannSchwartz/Reisman Emergency Medicine Institute (Grewal, Borgundvaag, McLeod), Sinai Health; Division of Emergency Medicine (Grewal, Atzema), Department of Medicine, University of Toronto; ICES Central ( Grewal, Atzema, Austin); Department of Emergency Services (Atzema), Sunnybrook Health Sciences Centre, Toronto, Ont.; Department of Emergency Medicine (de Wit), Queen's University, Kingston, Ont.; McMaster University (Sharma), Hamilton, Ont.; Sunnybrook Research Institute (Mittmann), Sunnybrook Health Sciences Centre; Department of Pharmacology and Toxicology, and Institute for Health Policy Management and Evaluation (Mittmann), and Department of Family and Community Medicine (Borgundvaag, McLeod), University of Toronto, Toronto, Ont.
Bjug BorgundvaagSchwartz/Reisman Emergency Medicine Institute (Grewal, Borgundvaag, McLeod), Sinai Health; Division of Emergency Medicine (Grewal, Atzema), Department of Medicine, University of Toronto; ICES Central ( Grewal, Atzema, Austin); Department of Emergency Services (Atzema), Sunnybrook Health Sciences Centre, Toronto, Ont.; Department of Emergency Medicine (de Wit), Queen's University, Kingston, Ont.; McMaster University (Sharma), Hamilton, Ont.; Sunnybrook Research Institute (Mittmann), Sunnybrook Health Sciences Centre; Department of Pharmacology and Toxicology, and Institute for Health Policy Management and Evaluation (Mittmann), and Department of Family and Community Medicine (Borgundvaag, McLeod), University of Toronto, Toronto, Ont.
Shelley L McLeodSchwartz/Reisman Emergency Medicine Institute (Grewal, Borgundvaag, McLeod), Sinai Health; Division of Emergency Medicine (Grewal, Atzema), Department of Medicine, University of Toronto; ICES Central ( Grewal, Atzema, Austin); Department of Emergency Services (Atzema), Sunnybrook Health Sciences Centre, Toronto, Ont.; Department of Emergency Medicine (de Wit), Queen's University, Kingston, Ont.; McMaster University (Sharma), Hamilton, Ont.; Sunnybrook Research Institute (Mittmann), Sunnybrook Health Sciences Centre; Department of Pharmacology and Toxicology, and Institute for Health Policy Management and Evaluation (Mittmann), and Department of Family and Community Medicine (Borgundvaag, McLeod), University of Toronto, Toronto, Ont.
Health Sciences Centre · CASchwartz/Reisman Emergency Medicine Institute · CASunnybrook Health Science Centre · CAUniversity of Toronto · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIntracranial hemorrhage (ICH) after head injury is a concern among older adult patients on anticoagulation. We evaluated the risk of ICH after an emergency department visit for head injury among patients 65 years and older taking warfarin or a direct oral anticoagulant (DOAC) compared with patients not taking anticoagulants. We also evaluated risk of 30-day mortality and neurosurgical intervention among patients with ICH.

methodsIn this retrospective cohort study, we used population-based data of patients 65 years and older seen in an Ontario emergency department with a head injury. We matched patients on the propensity score to create 3 pairwise-matched cohorts based on anticoagulation status (warfarin v. DOAC, warfarin v. no anticoagulant, DOAC v. no anticoagulant). For each cohort, we calculated the relative risk of ICH at the index emergency department visit and 30-day mortality. We also calculated the hazard of neurosurgical intervention among patients with ICH.

resultsWe identified 77 834 patients with head injury, including 64 917 (83.4%) who were not on anticoagulation, 9214 (11.8%) who were on DOACs and 3703 (4.8%) who were on warfarin. Of these, 5.9% of patients had ICH at the index emergency department visit. Patients on warfarin had an increased risk of ICH compared with matched patients on DOACs (relative risk [RR] 1.43, 95% confidence interval [CI] 1.20-1.69) and patients not on anticoagulation (RR 1.36, 95% CI 1.15-1.61). We did not observe a difference in ICH between patients on DOACs compared with matched patients not on anticoagulation. In patients with ICH, 30-day mortality did not differ by anticoagulation status or type. Patients on warfarin had an increased hazard of neurosurgery compared with patients not on anticoagulation.

interpretationPatients on warfarin seen in the emergency department with a head injury had higher relative risks of ICH than matched patients on a DOAC and patients not on anticoagulation, respectively. The risk of ICH for patients on a DOAC was not significantly different compared with no anticoagulation. Further research should confirm that older adults using warfarin are the only group at higher risk of ICH after head injury.

Indexed as

Accidental FallsAgedAnticoagulantsCraniocerebral TraumaEmergency Service, HospitalFemaleHospital MortalityHumansIntracranial HemorrhagesMaleOntarioRetrospective StudiesWarfarinAnticoagulantsWarfarin

Identifiers

PMID35040805
PMCPMC8568074
OpenAlexW3207623548

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.